DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Dermatologic Condition

Rosacea

LOW SEVERITY

A chronic inflammatory skin condition primarily affecting the face, characterized by facial redness, visible blood vessels, papules, and pustules. Often mistaken for acne or sunburn. Four subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea.

Global Affected

415.0M

Countries

15

Symptoms

Facial redness (flushing)
Visible blood vessels (telangiectasia)
Papules and pustules
Burning or stinging sensation
Eye problems (dryness, irritation)
Thickened skin (especially nose)
Skin sensitivity

Treatment Options

Topical metronidazole
Topical azelaic acid
Topical ivermectin
Topical brimonidine
Oral antibiotics (doxycycline, tetracycline)
Isotretinoin (severe cases)
Laser therapy
Intense pulsed light (IPL)
Surgical intervention (rhinophyma)
Eye care for ocular rosacea

Risk Factors

1Family history
2Fair skin
3Age (30-50)
4Female gender (more common)
5Sun exposure
6Hot drinks and spicy foods
7Alcohol
8Temperature extremes
9Stress
10Certain medications
11H. pylori infection (possible link)

Diagnostic Methods

  • 1Clinical diagnosis based on appearance
  • 2Medical history
  • 3Ruling out other conditions (lupus, acne)
  • 4Eye examination (if ocular symptoms)
  • 5No specific laboratory test

Prognosis

Chronic condition with no cure, but manageable with treatment. Symptoms may fluctuate over time. Early treatment prevents progression. Ocular rosacea requires ongoing management to prevent vision problems.

Prevention

  • Sun protection (SPF 30+ daily)
  • Identify and avoid triggers
  • Gentle skin care
  • Avoid harsh products
  • Manage stress
  • Limit alcohol and hot beverages
  • Protect from extreme temperatures
  • Regular follow-up with dermatologist

Research Status

Topical ivermectin and brimonidine are standard treatments. Oral doxycycline for inflammatory lesions. Laser and light therapies for redness and vessels. Research into microbiome connections and new targeted therapies ongoing.

Sources

  • https://www.hematology.org/education/patients
  • https://www.ncbi.nlm.nih.gov/books
  • https://rarediseases.org/rare-diseases

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.